• Checking the Boxes for Expanding Trial Start-ups to New Countries

    Clinical Research News | The patient-centered approach that has come into favor for planning and conducting clinical trials is, without question, improving care for trial participants. However, combined with other industry trends, including the proliferation of rare disease studies with much smaller patient pools, it is causing trial protocols to become more complex and is creating challenges in patient recruitment, which can lead to costly delays in a competitive and challenging macroeconomic environment.

    Nov 21, 2025

  • Early Rheumatoid Arthritis Studies Redefine Prevention and Clinical Research

    Clinical Research News | Rheumatoid arthritis has a reputation as a lifelong condition with no real cure and can only be managed after symptoms appear. However, researchers from the Allen Institute for Immunology, University of California, San Diego, and the University of Colorado Anschutz, have mapped out a way to detect dramatic immune system changes before the joints start swelling.

    Nov 19, 2025

  • Pioneering Platform for Collecting ‘Home-Reported Outcomes’

    Clinical Research News | As anyone contending with a complex chronic disease can likely attest, a lot has been “left on the table” when it comes to opportunities to achieve better health outcomes, lower costs, and greater personal satisfaction with their medical care. Tens of thousands of patients have voted for change by registering for the Folia Health app, which allows them to track their symptoms and share data about their own healthcare experiences with their care team or research studies.

    Nov 18, 2025

  • Making Sense of Sex in Clinical Trials

    Clinical Research News | Roughly two-thirds of pivotal clinical trials leading to a drug approval by the U.S. Food and Drug Administration (FDA) now include women at rates either at or above the disease burden on the female population. Yet progress on their inclusion has “plateaued” since the FDA began releasing its Drug Trials Snapshots in 2015 because of “fundamental issues in not considering female biology."

    Nov 12, 2025

  • Less Can Be More When It Comes to Collecting Data in Studies

    Clinical Research News | It is no secret that clinical trial protocols have grown increasingly complex, resulting in longer study durations, higher costs, and greater burden on patients and investigative sites. It has been a consistent, well-documented trend for more than two decades now.

    Nov 11, 2025

  • Next-Gen Weight-Loss Drug Moves Closer to Clinical Trials

    Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

    Nov 6, 2025

  • Site Payments: Transparency, Timeliness, and Trust

    Clinical Research News | Developing a “super-tolerable” weight loss drug is one of the biggest challenges in obesity medicine today. Researchers recently reported the creation of a promising molecule, tridecaneuropeptide (TDN), which reduces food intake without triggering the awful side effects often associated with glucagon-like peptide-1 (GLP-1) drugs such as Ozempic and Zepbound.

    Nov 5, 2025

  • AI in Clinical Trials: Industry Leaders Discuss Implementation Challenges and Future Directions

    Clinical Research News | At SCOPE Europe, I hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes.

    Nov 4, 2025

  • AI in Clinical Trials: Industry Leaders Discuss Implementation Challenges and Future Directions

    Clinical Research News | At SCOPE Europe, Allison Proffitt hosted a panel of pharmaceutical industry leaders to discuss the real-world implementation of artificial intelligence in clinical trials, moving beyond theoretical benefits to address practical challenges and measurable outcomes.

    Nov 4, 2025